[Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening]. / La fréquence du syndrome hémolytique et urémique secondaire à la gemcitabine est-elle sous-estimée? Intérêt d'un dépistage sytématique.
Gastroenterol Clin Biol
; 30(2): 332-4, 2006 Feb.
Article
in Fr
| MEDLINE
| ID: mdl-16565677
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Deoxycytidine
/
Hemolytic-Uremic Syndrome
/
Antimetabolites, Antineoplastic
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Fr
Journal:
Gastroenterol Clin Biol
Year:
2006
Document type:
Article